J J Hoefnagel

Summary

Affiliation: Leiden University Medical Center
Country: The Netherlands

Publications

  1. ncbi Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases
    J J Hoefnagel
    Department of Dermatology B1 Q, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    Arch Dermatol 141:1139-45. 2005
  2. ncbi Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma
    Juliette J Hoefnagel
    Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
    Mod Pathol 19:1270-6. 2006
  3. ncbi Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance
    J J Hoefnagel
    Department of Dermatology, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands
    Br J Dermatol 149:1183-91. 2003
  4. ncbi Profiling of apoptosis genes identifies distinct types of primary cutaneous large B cell lymphoma
    J C van Galen
    Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands
    J Pathol 215:340-6. 2008
  5. ncbi Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling
    Juliette J Hoefnagel
    Department of Dermatology, B1-Q, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    Blood 105:3671-8. 2005
  6. ncbi Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers
    Nancy J Senff
    Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
    J Clin Oncol 25:1581-7. 2007
  7. ncbi Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification
    Nancy J Senff
    Department of Dermatology, B1 Q, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    Arch Dermatol 143:1520-6. 2007
  8. ncbi Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma
    Remco Dijkman
    Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
    J Clin Oncol 24:296-305. 2006

Collaborators

Detail Information

Publications8

  1. ncbi Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases
    J J Hoefnagel
    Department of Dermatology B1 Q, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    Arch Dermatol 141:1139-45. 2005
    ..We describe 50 patients with PCMZL to further characterize clinical characteristics and outcome and, in particular, to evaluate our current therapeutic approach...
  2. ncbi Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma
    Juliette J Hoefnagel
    Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
    Mod Pathol 19:1270-6. 2006
    ....
  3. ncbi Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance
    J J Hoefnagel
    Department of Dermatology, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, The Netherlands
    Br J Dermatol 149:1183-91. 2003
    ....
  4. ncbi Profiling of apoptosis genes identifies distinct types of primary cutaneous large B cell lymphoma
    J C van Galen
    Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands
    J Pathol 215:340-6. 2008
    ..Thus, strategies neutralizing the function of apoptosis-inhibiting proteins might be effective in PCLBCL leg-type...
  5. ncbi Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling
    Juliette J Hoefnagel
    Department of Dermatology, B1-Q, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    Blood 105:3671-8. 2005
    ..The results of this study suggest that different pathogenetic mechanisms are involved in the development of PCFCCLs and PCLBCLs-leg and provide molecular support for the subdivision used in the EORTC classification...
  6. ncbi Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers
    Nancy J Senff
    Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
    J Clin Oncol 25:1581-7. 2007
    ..This study aimed to assess the clinical significance of the new classification compared with previous classification schemes (EORTC 1997; WHO 2001) and to define prognostic factors within the newly defined categories...
  7. ncbi Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification
    Nancy J Senff
    Department of Dermatology, B1 Q, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands
    Arch Dermatol 143:1520-6. 2007
    ....
  8. ncbi Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma
    Remco Dijkman
    Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands
    J Clin Oncol 24:296-305. 2006
    ..Inactivation of CDKN2A by either deletion or methylation of its promoter could be an important prognostic parameter for the group of PCLBCL, leg type...